S446 Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents With EoE

Authors:
  • EDEvan Dellon
    Evan Dellon
  • MCMirna Chehade
    Mirna Chehade
  • RGRobert M. Genta
    Robert M. Genta
  • DLDavid A. Leiman
    David A. Leiman
  • KPKathryn A. Peterson
    Kathryn A. Peterson
  • JSJonathan Spergel
    Jonathan Spergel
  • JWJoshua Wechsler
    Joshua Wechsler
  • EBEnoch Bortey
    Enoch Bortey
  • ACAlan T. Chang
    Alan T. Chang
  • IHIkuo Hirano
    Ikuo Hirano
Publisher website
Google Scholar
Abstract
No abstract available